These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

297 related articles for article (PubMed ID: 7422532)

  • 1. Plasma levels of isosorbide dinitrate and the isosorbide mononitrates after increasing doses of a retard preparation of isosorbide dinitrate.
    Bogaert MG; Rosseel MT
    Nouv Presse Med; 1980 Sep; 9(34 Suppl):2424-7. PubMed ID: 7422532
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Plasma concentrations of isosorbide dinitrate after administration of increasing doses of a sustained-release formulation to human subjects.
    Taylor T; O'Kelly DA; Major RM; Darragh A; Chasseaud LF
    Arzneimittelforschung; 1978; 28(8):1426-8. PubMed ID: 582411
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Dose-effect relationship of isosorbide dinitrate in the treatment of angina pectoris (author's transl)].
    Schneider W; Stahl B; Kaltenbach M; Bussmann WD
    Dtsch Med Wochenschr; 1982 May; 107(20):771-6. PubMed ID: 7075499
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Comparison of the effects of molsidomine retard and isosorbide dinitrate retard in patients with stable angina pectoris using an ergometry test].
    Rotrekl P; Vlasínová J; Manousek J; Semrád B; Rysavý F; Lupínek Z; Meluzín J; Vlasicová I; Pirochtová I; Bocek O
    Vnitr Lek; 1993 Sep; 39(9):856-64. PubMed ID: 8212639
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Plasma concentrations of isosorbide dinitrate after oral administration of a sustained-release formulation to human subjects.
    Assinder DF; Chasseaud LF; Hunter JO; Jung RJ; Taylor T
    Arzneimittelforschung; 1977; 27(1):156-8. PubMed ID: 576817
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy of isosorbide dinitrate tape on exercise tolerance of patients with angina pectoris.
    Saito M; Nobuyoshi M; Nakamura N; Nishiyama S; Haze K; Hiramori K; Ikeda M
    Arzneimittelforschung; 1983; 33(9):1301-5. PubMed ID: 6685512
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Oral isosorbide dinitrate in angina pectoris: comparison of duration of action an dose-response relation during acute and sustained therapy.
    Thadani U; Fung HL; Darke AC; Parker JO
    Am J Cardiol; 1982 Feb; 49(2):411-9. PubMed ID: 7058754
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Bioavailability of 2 different depot formulations with 40 mg of isosorbide dinitrate].
    Segre G; Zanolo G; Mondino A; Giachetti C; Silvestri S
    Fortschr Med; 1981 Dec; 99(47-48):2008-13. PubMed ID: 7327496
    [No Abstract]   [Full Text] [Related]  

  • 9. [Long-term percutaneous therapy of angina pectoris with isosorbide dinitrate with reference to isosorbide dinitrate blood levels].
    Kriehuber E; Prey T; Orthofer R
    Wien Med Wochenschr; 1982 Jun; 132(12):295-302. PubMed ID: 7123974
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Development of nitrate tolerance in individual patients with stable angina pectoris in various phases of therapy with oral isosorbide dinitrate].
    Kośmicki M; Szwed H; Kowalik I; Sadowski Z
    Pol Merkur Lekarski; 2002 Jul; 13(73):52-5. PubMed ID: 12362508
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Plasma concentrations of isosorbide dinitrate and mononitrates after acute and chronic oral administration of isosorbide dinitrate in man.
    Bruyneel K; Rosseel MT; Bogaert MG
    Arzneimittelforschung; 1982; 32(7):769-73. PubMed ID: 6889879
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Comparative pharmacokinetics and bioavailability of isosorbide dinitrate and its metabolites isosorbide 5- and 2-mononitrate from delayed-release preparations].
    Geigenberger A; Degen J; Maier-Lenz H
    Arzneimittelforschung; 1982; 32(9):1138-40. PubMed ID: 6890839
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sustained hemodynamic and antianginal effects of high dose oral isosorbide dinitrate.
    Aronow S
    Nouv Presse Med; 1980 Sep; 9(34 Suppl):2483-6. PubMed ID: 7422537
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Treatment of angina pectoris with beta-receptor blockaders a slow-releasing isosorbide dinitrate preparation].
    Kappenberger L; Fellmann H; Nager F
    Schweiz Med Wochenschr; 1973 Dec; 103(50):1789-92. PubMed ID: 4149035
    [No Abstract]   [Full Text] [Related]  

  • 15. Efficacy of eccentric dosing with sustained-release isosorbide dinitrate in patients with angina pectoris.
    Parker JO; Baird MG
    Can J Cardiol; 1994 Nov; 10(9):909-12. PubMed ID: 7954026
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Pharmacokinetics and pharmacodynamics of a new 80 mg oral delayed-action isosorbide dinitrate preparation].
    Pello JY; Auclert L; Rey E; Joly H; Mialet C; Puechavy C; Georges M; Ruffo M; Olive G
    Arch Mal Coeur Vaiss; 1992 Apr; 85 Spec No 1():13-6. PubMed ID: 1530422
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of antianginal efficacy of sustained release isosorbide dinitrate with short-acting isosorbide dinitrate.
    Joseph G
    Indian Heart J; 1991; 43(6):477. PubMed ID: 1823901
    [No Abstract]   [Full Text] [Related]  

  • 18. Clinical effects of a sustained-release preparation of isosorbide dinitrate on angina pectoris.
    Arakawa K; Fujino M
    Clin Ther; 1980; 3(2):103-16. PubMed ID: 6778614
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High-dosage isosorbide dinitrate therapy for angina.
    Tremblay G; Biron P; Désourdy F
    Can Med Assoc J; 1983 Mar; 128(6):679-81. PubMed ID: 6825033
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Duration of effects of isosorbide dinitrate retard in coronary disease].
    Raab C; Schindler J; Rahlfs VW
    Med Welt; 1977 Nov; 28(44):1807-9. PubMed ID: 593121
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 15.